Search Results 1431-1440 of 42802 for oral
Regorafenib is a type of drug called a kinase inhibitor. Regorafenib interferes with how some kinase proteins work. Some of these kinases in cancer cells might ...
Clinical Trials · A Study To Evaluate Effectiveness Of 2 Doses Of Oral CXA-10 In Pulmonary Arterial Hypertension (PAH) · More about research at Mayo Clinic · Mayo ...
TP-0903 is a novel oral inhibitor that targets AXL kinase. Preclinical studies have shown promising antitumor activity of TP-0903 as a single agent against ...
About this study. The primary hypothesis of the study is that treatment with either once-daily or twice-daily pacritinib results in a greater proportion of ...
This is a multicenter, randomized (1:1; oral treprostinil to placebo), double-blind, placebo-controlled study in subjects with World Health Organization (WHO) ...
The purpose of this study is to demonstrate the effect of oral ozanimod as maintenance therapy in subjects with moderately to severely active Crohn's Disease.
Oral and injectable medications for type 2 diabetes. American Diabetes Association. https://diabetes.org/health-wellness/medication/oral-other-injectable ...
Ask your doctor if you have any questions. You may take this medicine with or without food. Measure the oral liquid correctly using the marked dosing cup that ...
The purpose of this study is to assess the effect of 4 weeks of kavalactone dosing on cortisol in a healthy nursing population. Secondary aims will assess ...
Peripheral ameloblastoma. This type is rare and affects the gums and oral tissue in the upper or lower jaw. The tumor has a low risk of recurrence after ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.